In modern medicine, few specialties are as demanding and high-risk as lung transplantation. Yet Dr. Ankit Bharat has built a national reputation by tackling some of the most complex and seemingly impossible cases in thoracic surgery.
As chief of thoracic surgery and executive director of the Northwestern Medicine Canning Thoracic Institute, Bharat has become known for combining surgical innovation with life-saving experimental techniques that are helping redefine what is medically possible.
Bharat first gained widespread national attention during the COVID-19 pandemic, when he led pioneering lung transplant procedures for patients suffering catastrophic lung damage caused by the virus. Since then, his work has continued to push boundaries in transplant medicine and critical care innovation.

One of the most remarkable recent examples came in 2026, when Bharat and his team successfully kept a patient alive for 48 hours without functioning lungs by using a custom-engineered artificial lung support system before completing a double-lung transplant. The patient had developed a severe antibiotic-resistant infection that destroyed both lungs, leaving surgeons with virtually no traditional treatment options.
According to Northwestern Medicine, Bharat’s team removed both infected lungs entirely while the patient remained connected to an external artificial lung system designed to temporarily replace pulmonary function. After nearly two days on the system, the patient successfully received a double-lung transplant. The achievement represented a major advancement in thoracic surgery and critical care medicine.
Medical experts around the country viewed the procedure as a significant breakthrough because it demonstrated that artificial lung systems may eventually help more critically ill patients survive long enough to receive organ transplants.
Born in India, Bharat completed medical training before eventually building his surgical career in the United States. Over the years, he became recognized for his expertise in thoracic surgery, lung transplantation, and complex respiratory disease treatment. At Northwestern Medicine, he now leads one of the country’s most respected transplant and thoracic surgery programs.
Much of Bharat’s work focuses on improving survival outcomes for patients facing severe respiratory failure. During the COVID era, he and his team helped establish new standards for evaluating and treating patients whose lungs had suffered irreversible viral damage. Several of those transplant procedures received international media coverage and contributed to evolving transplant protocols nationwide.
Colleagues often describe Bharat as both highly technical and deeply patient-focused. While his surgical innovations attract headlines, many patients and families speak just as strongly about his communication style and commitment during difficult treatment journeys.
Beyond performing surgeries, Bharat is also heavily involved in clinical research and medical education. His research explores new transplant preservation methods, artificial organ support systems, and ways to reduce complications following major thoracic procedures.
The broader significance of Bharat’s work extends far beyond a single hospital or surgical specialty. As organ shortages continue to challenge healthcare systems worldwide, innovations in artificial organ support could dramatically change how transplant medicine operates in the future.
For younger physicians entering medicine today, Bharat represents a growing type of healthcare leader: a doctor equally comfortable inside the operating room, the research lab, and the innovation ecosystem driving next-generation healthcare technologies.
At a time when medicine increasingly depends on interdisciplinary collaboration between surgeons, engineers, and critical care specialists, Bharat’s career offers a powerful example of how innovation and clinical expertise can work together to save lives once considered beyond rescue.

And while many of his procedures remain highly complex and experimental, they are also helping shape the future of respiratory medicine for patients around the world.




